Introduktion

Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Murray A Goldberg. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.

Genomsnittlig handelslönsamhet

Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.

Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.

Uppdateringsfrekvens: Dagligen

Se listan över mest lönsamma insiderhandlare

Företag med rapporterade insiderpositioner

SEC-anmälningarna visar att Murray A Goldberg har rapporterat innehav eller affärer i följande företag:

Värdepapper Titel Senaste rapporterade innehav
US:AYLA / Ayala Pharmaceuticals Inc Director 6 250
US:AERI / Aerie Pharmaceuticals Inc Director 0
US:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Director 17 621
US:REGN / Regeneron Pharmaceuticals, Inc. SVP Administration & Asst Secr 78 079
Hur man tolkar diagrammen

Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Murray A Goldberg. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.

I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.

Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.

Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.

Insiderhandelshistorik

Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Murray A Goldberg som avslöjats för Securities Exchange Commission (SEC).

Fildatum Transaktionsdatum Schema Ticker Värdepapper Kode 10b5-1 Aktier Återstående aktier Procentuell förandring Aktie
pris
Transaktionsvärde Återstående
värde
2021-06-14 2021-06-10 4 AYLA Ayala Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 6 250 6 250
2020-05-20 2020-05-18 4 AERI AERIE PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise −28 000 0 −100,00
2020-05-20 2020-05-18 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
M - Exercise 28 000 36 050 347,83 3,15 88 200 113 558
2019-06-13 2019-06-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 17 621 17 621
2019-05-24 2019-05-23 4 AERI AERIE PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 7 800 7 800
2019-05-24 2019-05-23 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
A - Award 1 750 8 050 27,78
2018-06-08 2018-06-07 4 AERI AERIE PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 7 800 7 800
2018-06-08 2018-06-07 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
A - Award 1 750 6 300 38,46
2018-06-07 2018-06-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 6 041 6 041
2017-06-09 2017-06-08 4 AERI AERIE PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 10 000 10 000
2017-06-09 2017-06-08 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
A - Award 1 150 4 550 33,82
2016-06-09 2016-06-08 4 AERI AERIE PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 10 000 10 000
2016-06-09 2016-06-08 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
A - Award 1 700 3 400 100,00
2015-04-14 2015-04-10 4 AERI AERIE PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 10 000 10 000
2015-04-14 2015-04-10 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
A - Award 1 700 1 700
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 60 000 78 079 331,88
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise −3 264 0 −100,00
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 3 264 64 436 5,34 30,63 99 976 1 973 675
2014-12-18 2014-11-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift −1 930 61 172 −3,06
2014-10-27 2014-10-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 035 63 102 −1,61 404,18 −418 326 25 504 566
2014-10-27 2014-10-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −2 454 64 137 −3,69 403,50 −990 189 25 879 280
2014-10-27 2014-10-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −2 500 66 591 −3,62 402,54 −1 006 350 26 805 541
2014-10-27 2014-10-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −5 293 69 091 −7,12 401,51 −2 125 192 27 740 727
2014-10-27 2014-10-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −7 531 74 384 −9,19 400,51 −3 016 241 29 791 536
2014-10-27 2014-10-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −3 200 81 915 −3,76 399,37 −1 277 984 32 714 394
2014-10-27 2014-10-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −2 100 85 115 −2,41 398,58 −837 018 33 925 137
2014-10-27 2014-10-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 700 87 215 −1,91 397,65 −676 005 34 681 045
2014-10-27 2014-10-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −775 88 915 −0,86 396,80 −307 520 35 281 472
2014-10-27 2014-10-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −200 89 690 −0,22 395,96 −79 192 35 513 652
2014-10-27 2014-10-23 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −60 000 6 736 −89,91
2014-10-27 2014-10-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −28 523 89 890 −24,09 391,93 −11 179 019 35 230 588
2014-10-27 2014-10-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −4 689 118 413 −3,81 391,93 −1 837 760 46 409 607
2014-10-27 2014-10-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 60 000 123 102 95,08 30,63 1 837 800 3 770 614
2014-06-13 2014-06-11 4 AERI AERIE PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 13 500 13 500
2014-02-26 2014-02-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −300 63 102 −0,47 346,73 −104 019 21 879 356
2014-02-26 2014-02-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −100 63 402 −0,16 345,02 −34 502 21 874 958
2014-02-26 2014-02-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −200 63 502 −0,31 344,47 −68 894 21 874 534
2014-02-26 2014-02-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −500 63 702 −0,78 342,19 −171 095 21 798 187
2014-02-26 2014-02-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −2 100 64 202 −3,17 341,46 −717 066 21 922 415
2014-02-26 2014-02-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 200 66 302 −1,78 340,43 −408 516 22 571 190
2014-02-26 2014-02-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 300 67 502 −1,89 339,20 −440 960 22 896 678
2014-02-26 2014-02-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −3 934 68 802 −5,41 338,37 −1 331 148 23 280 533
2014-02-26 2014-02-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 962 72 736 −2,63 337,40 −661 979 24 541 126
2014-02-26 2014-02-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −275 74 698 −0,37 336,89 −92 645 25 165 009
2014-02-26 2014-02-24 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −3 893 0 −100,00
2014-02-26 2014-02-24 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −6 334 0 −100,00
2014-02-26 2014-02-24 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −20 000 18 079 −52,52
2014-02-26 2014-02-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −1 479 74 973 −1,93 342,63 −506 750 25 687 999
2014-02-26 2014-02-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −1 023 76 452 −1,32 342,63 −350 510 26 194 749
2014-02-26 2014-02-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 3 893 77 475 5,29 90,07 350 643 6 978 173
2014-02-26 2014-02-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −8 747 73 582 −10,62 342,63 −2 996 985 25 211 401
2014-02-26 2014-02-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −3 036 82 329 −3,56 342,63 −1 040 225 28 208 385
2014-02-26 2014-02-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 20 000 85 365 30,60 52,03 1 040 600 4 441 541
2014-02-26 2014-02-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −2 407 65 365 −3,55 342,63 −824 710 22 396 010
2014-02-26 2014-02-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −1 664 67 772 −2,40 342,63 −570 136 23 220 720
2014-02-26 2014-02-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 6 334 69 436 10,04 90,07 570 503 6 254 101
2014-02-24 2014-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −2 203 63 102 −3,37 339,31 −747 500 21 411 140
2014-02-24 2014-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −5 204 65 305 −7,38 338,51 −1 761 606 22 106 396
2014-02-24 2014-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −2 126 70 509 −2,93 337,51 −717 546 23 797 493
2014-02-24 2014-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −4 158 72 635 −5,41 336,42 −1 398 834 24 435 867
2014-02-24 2014-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −3 143 76 793 −3,93 335,67 −1 055 011 25 777 106
2014-02-24 2014-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −2 824 79 936 −3,41 334,45 −944 487 26 734 595
2014-02-24 2014-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −300 82 760 −0,36 333,90 −100 170 27 633 564
2014-02-24 2014-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −400 83 060 −0,48 332,67 −133 068 27 631 570
2014-02-24 2014-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −500 83 460 −0,60 328,50 −164 250 27 416 610
2014-02-24 2014-02-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −400 83 960 −0,47 327,84 −131 136 27 525 446
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −10 424 0 −100,00
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −4 168 0 −100,00
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −2 976 0 −100,00
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −3 084 0 −100,00
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −30 000 66 736 −31,01
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −996 84 360 −1,17 326,05 −324 746 27 505 578
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −535 85 356 −0,62 326,05 −174 437 27 830 324
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 3 084 85 891 3,72 56,61 174 585 4 862 290
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −1 225 82 807 −1,46 326,05 −399 411 26 999 222
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −600 84 032 −0,71 326,05 −195 630 27 398 634
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 2 976 84 632 3,64 65,76 195 702 5 565 400
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −1 670 81 656 −2,00 326,05 −544 504 26 623 939
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −927 83 326 −1,10 326,05 −302 248 27 168 442
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 4 168 84 253 5,20 72,60 302 597 6 116 768
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −4 064 80 085 −4,83 326,05 −1 325 067 26 111 714
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −2 542 84 149 −2,93 326,05 −828 819 27 436 781
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 10 424 86 691 13,67 79,53 829 021 6 894 535
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −14 017 76 267 −15,53 326,05 −4 570 243 24 866 855
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −2 818 90 284 −3,03 326,05 −918 809 29 437 098
2014-02-24 2014-02-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 30 000 93 102 47,54 30,63 918 900 2 851 714
2013-12-19 2013-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise −4 705 0 −100,00
2013-12-19 2013-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 4 705 63 102 8,06 21,25 99 981 1 340 918
2013-12-17 2013-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −5 157 58 397 −8,11 272,73 −1 406 469 15 926 614
2013-12-17 2013-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 15 000 15 000
2013-12-17 2013-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 60 000 96 736 163,33
2013-08-02 2013-08-01 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise −5 000 0 −100,00
2013-08-02 2013-08-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 5 000 63 554 8,54 16,80 84 000 1 067 707
2013-05-22 2013-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise −3 071 0 −100,00
2013-05-22 2013-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise −952 5 000 −15,99
2013-05-22 2013-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −3 000 58 554 −4,87 264,61 −793 830 15 493 974
2013-05-22 2013-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −2 200 61 554 −3,45 263,89 −580 558 16 243 485
2013-05-22 2013-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 910 63 754 −2,91 262,14 −500 687 16 712 474
2013-05-22 2013-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −8 774 65 664 −11,79 261,36 −2 293 173 17 161 943
2013-05-22 2013-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −18 542 74 438 −19,94 260,57 −4 831 489 19 396 310
2013-05-22 2013-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −8 566 92 980 −8,44 259,48 −2 222 706 24 126 450
2013-05-22 2013-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −8 989 101 546 −8,13 258,54 −2 324 016 26 253 703
2013-05-22 2013-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −3 516 110 535 −3,08 257,59 −905 686 28 472 711
2013-05-22 2013-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −9 561 114 051 −7,73 256,61 −2 453 448 29 266 627
2013-05-22 2013-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 777 123 612 −1,42 255,52 −454 059 31 585 338
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −3 919 0 −100,00
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −3 750 4 670 −44,54
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −15 000 8 420 −64,05
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −6 250 23 420 −21,07
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −50 000 29 670 −62,76
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −20 000 0 −100,00
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −20 000 0 −100,00
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −16 250 40 000 −28,89
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −12 798 56 250 −18,53
2013-05-22 2013-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 3 071 125 389 2,51 20,32 62 403 2 547 904
2013-05-22 2013-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 952 122 318 0,78 16,80 15 994 2 054 942
2013-05-22 2013-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift −4 061 121 366 −3,24
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −9 116 125 427 −6,78 266,64 −2 430 690 33 443 855
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −1 260 134 543 −0,93 266,64 −335 966 35 874 546
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 20 000 135 803 17,27 16,80 336 000 2 281 490
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −9 664 115 803 −7,70 266,64 −2 576 809 30 877 712
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −1 260 125 467 −0,99 266,64 −335 966 33 454 521
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 20 000 126 727 18,74 16,80 336 000 2 129 014
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −7 852 106 727 −6,85 266,64 −2 093 657 28 457 687
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −1 023 114 579 −0,88 266,64 −272 773 30 551 345
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 16 250 115 602 16,36 16,80 273 000 1 942 114
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −1 617 99 352 −1,60 266,64 −431 157 26 491 217
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −781 100 969 −0,77 266,64 −208 246 26 922 374
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 3 919 101 750 4,01 53,18 208 412 5 411 065
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −6 184 97 831 −5,95 266,64 −1 648 902 26 085 658
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −806 104 015 −0,77 266,64 −214 912 27 734 560
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 12 798 104 821 13,91 16,80 215 006 1 760 993
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −1 779 92 023 −1,90 266,64 −474 353 24 537 013
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −298 93 802 −0,32 266,64 −79 459 25 011 365
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 3 750 94 100 4,15 21,25 79 688 1 999 625
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −7 119 90 350 −7,30 266,64 −1 898 210 24 090 924
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −1 195 97 469 −1,21 266,64 −318 635 25 989 134
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 15 000 98 664 17,93 21,25 318 750 2 096 610
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −2 966 83 664 −3,42 266,64 −790 854 22 308 169
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −498 86 630 −0,57 266,64 −132 787 23 099 023
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 6 250 87 128 7,73 21,25 132 812 1 851 470
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −23 730 80 878 −22,68 266,64 −6 327 367 21 565 310
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −3 984 104 608 −3,67 266,64 −1 062 294 27 892 677
2013-05-22 2013-05-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 50 000 108 592 85,34 21,25 1 062 500 2 307 580
2013-01-17 2013-01-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −200 58 592 −0,34 174,56 −34 912 10 227 820
2013-01-17 2013-01-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −2 227 58 792 −3,65 173,37 −386 095 10 192 769
2013-01-17 2013-01-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −2 200 61 019 −3,48 172,77 −380 094 10 542 253
2013-01-17 2013-01-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 200 63 219 −1,86 171,11 −205 332 10 817 403
2013-01-17 2013-01-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −2 051 64 419 −3,09 170,57 −349 839 10 987 949
2012-12-18 2012-12-17 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise −1 850 3 071 −37,59
2012-12-18 2012-12-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift −3 400 750 −81,93
2012-12-18 2012-12-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 1 850 66 470 2,86 20,32 37 592 1 350 670
2012-12-18 2012-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 84 500 84 500
2012-12-18 2012-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 56 250 79 670 240,18
2012-12-18 2012-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −4 607 64 620 −6,65 179,13 −825 252 11 575 381
2012-12-18 2012-12-10 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift −6 100 4 150 −59,51
2012-12-18 2012-12-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift −4 250 10 250 −29,31
2012-12-18 2012-12-03 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift 14 500 14 500
2012-12-18 2012-12-03 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift −14 500 69 227 −17,32
2012-12-18 2012-11-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift −250 83 727 −0,30
2012-11-15 2012-11-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −700 83 977 −0,83 149,18 −104 426 12 527 689
2012-11-15 2012-11-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −900 84 677 −1,05 148,65 −133 785 12 587 236
2012-11-15 2012-11-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 556 85 577 −1,79 147,65 −229 743 12 635 444
2012-11-15 2012-11-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −4 745 0 −100,00
2012-11-15 2012-11-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −3 431 0 −100,00
2012-11-15 2012-11-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −792 87 133 −0,90 148,05 −117 256 12 900 041
2012-11-15 2012-11-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −3 845 87 925 −4,19 147,62 −567 599 12 979 488
2012-11-15 2012-11-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 400 91 770 −1,50 146,58 −205 212 13 451 647
2012-11-15 2012-11-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −300 93 170 −0,32 145,65 −43 695 13 570 210
2012-11-15 2012-11-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −200 93 470 −0,21 144,36 −28 872 13 493 329
2012-11-15 2012-11-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −1 489 93 670 −1,56 146,60 −218 287 13 732 022
2012-11-15 2012-11-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −198 95 159 −0,21 146,60 −29 027 13 950 309
2012-11-15 2012-11-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 3 431 95 357 3,73 8,50 29 164 810 534
2012-11-15 2012-11-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −1 205 91 926 −1,29 146,60 −176 653 13 476 352
2012-11-15 2012-11-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −2 128 93 131 −2,23 146,60 −311 965 13 653 005
2012-11-15 2012-11-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 4 745 95 259 5,24 65,76 312 031 6 264 232
2012-09-04 2012-08-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −476 90 514 −0,52 147,21 −70 072 13 324 566
2012-09-04 2012-08-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 626 90 990 −1,76 146,37 −237 998 13 318 206
2012-09-04 2012-08-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −2 691 92 616 −2,82 145,60 −391 810 13 484 890
2012-09-04 2012-08-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −503 95 307 −0,52 144,59 −72 729 13 780 439
2012-09-04 2012-07-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift −600 95 810 −0,62
2012-05-22 2012-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise −4 562 0 −100,00
2012-05-22 2012-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise −11 682 0 −100,00
2012-05-22 2012-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 11 682 96 410 13,79 11,64 135 978 1 122 212
2012-05-22 2012-05-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 4 562 84 728 5,69 21,92 99 999 1 857 238
2012-05-04 2012-05-03 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −100 80 166 −0,12 138,48 −13 848 11 101 388
2012-05-04 2012-05-03 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −700 80 266 −0,86 137,19 −96 033 11 011 693
2012-05-04 2012-05-03 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −4 211 80 966 −4,94 136,34 −574 128 11 038 904
2012-05-04 2012-05-03 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −6 265 85 177 −6,85 135,60 −849 534 11 550 001
2012-05-04 2012-05-03 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −7 294 91 442 −7,39 134,47 −980 824 12 296 206
2012-05-04 2012-05-03 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −5 872 98 736 −5,61 133,51 −783 971 13 182 243
2012-05-04 2012-05-03 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −200 104 608 −0,19 132,96 −26 592 13 908 680
2012-05-04 2012-05-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award X 4 088 8 749 87,71
2012-05-04 2012-05-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award X 4 661 4 661
2012-05-04 2012-05-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −29 000 0 −100,00
2012-05-04 2012-05-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −25 438 29 000 −46,73
2012-05-04 2012-05-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −11 212 104 808 −9,66 136,37 −1 528 980 14 292 667
2012-05-04 2012-05-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −4 661 116 020 −3,86 136,37 −635 621 15 821 647
2012-05-04 2012-05-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 29 000 120 681 31,63 21,92 635 680 2 645 328
2012-05-04 2012-05-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −9 835 91 681 −9,69 136,37 −1 341 199 12 502 538
2012-05-04 2012-05-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −4 088 101 516 −3,87 136,37 −557 481 13 843 737
2012-05-04 2012-05-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 25 438 105 604 31,73 21,92 557 601 2 314 840
2012-05-04 2012-05-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −2 990 80 166 −3,60 138,28 −413 457 11 085 354
2012-05-04 2012-05-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 355 83 156 −1,60 137,52 −186 340 11 435 613
2012-05-04 2012-05-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −800 84 511 −0,94 136,63 −109 304 11 546 738
2012-05-04 2012-05-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −600 85 311 −0,70 135,33 −81 198 11 545 138
2012-05-04 2012-05-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 200 85 911 −1,38 134,64 −161 568 11 567 057
2012-02-08 2012-02-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −500 87 111 −0,57 101,35 −50 675 8 828 700
2012-02-08 2012-02-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −3 735 87 611 −4,09 100,42 −375 069 8 797 897
2012-02-08 2012-02-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −13 265 91 346 −12,68 99,67 −1 322 123 9 104 456
2012-02-08 2012-02-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −12 788 0 −100,00
2012-02-08 2012-02-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −9 375 23 420 −28,59
2012-02-08 2012-02-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −18 750 69 048 −21,36
2012-02-08 2012-02-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −4 400 104 611 −4,04 98,23 −432 212 10 275 939
2012-02-08 2012-02-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −3 236 109 011 −2,88 98,23 −317 872 10 708 151
2012-02-08 2012-02-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 12 788 112 247 12,86 24,86 317 910 2 790 460
2012-02-08 2012-02-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −3 384 99 459 −3,29 98,23 −332 410 9 769 858
2012-02-08 2012-02-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −2 027 102 843 −1,93 98,23 −199 112 10 102 268
2012-02-08 2012-02-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 9 375 104 870 9,82 21,25 199 219 2 228 488
2012-02-08 2012-02-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −7 160 95 495 −6,97 98,23 −703 327 9 380 474
2012-02-08 2012-02-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −3 206 102 655 −3,03 98,23 −314 925 10 083 801
2012-02-08 2012-02-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 18 750 105 861 21,52 16,80 315 000 1 778 465
2012-02-02 2012-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −100 87 111 −0,11 93,04 −9 304 8 104 807
2012-02-02 2012-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −7 992 87 211 −8,39 92,22 −737 022 8 042 598
2012-02-02 2012-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −7 151 95 203 −6,99 91,71 −655 818 8 731 067
2012-02-02 2012-02-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −3 015 102 354 −2,86 90,64 −273 280 9 277 367
2012-02-02 2012-01-31 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award X 3 893 3 893
2012-02-02 2012-01-31 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award X 6 334 6 334
2012-02-02 2012-01-31 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −16 000 54 438 −22,72
2012-02-02 2012-01-31 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −28 079 1 200 −95,90
2012-02-02 2012-01-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −5 577 105 369 −5,03 90,07 −502 320 9 490 586
2012-02-02 2012-01-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −3 893 110 946 −3,39 90,07 −350 643 9 992 906
2012-02-02 2012-01-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 16 000 114 839 16,19 21,92 350 720 2 517 271
2012-02-02 2012-01-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −10 017 98 839 −9,20 90,07 −902 231 8 902 429
2012-02-02 2012-01-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −6 334 108 856 −5,50 90,07 −570 503 9 804 660
2012-02-02 2012-01-31 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 28 079 115 190 32,23 20,32 570 565 2 340 661
2012-02-02 2012-01-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift −2 250 87 111 −2,52
2012-01-23 2012-01-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −400 89 361 −0,45 79,51 −31 804 7 105 093
2012-01-23 2012-01-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −3 216 89 761 −3,46 78,17 −251 395 7 016 617
2012-01-23 2012-01-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −13 567 92 977 −12,73 77,86 −1 056 327 7 239 189
2012-01-23 2012-01-19 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award X 10 424 10 424
2012-01-23 2012-01-19 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −40 800 29 279 −58,22
2012-01-23 2012-01-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −13 193 106 544 −11,02 79,53 −1 049 239 8 473 444
2012-01-23 2012-01-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −10 424 119 737 −8,01 79,53 −829 021 9 522 684
2012-01-23 2012-01-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 40 800 130 161 45,66 20,32 829 056 2 644 872
2005-12-28 2005-12-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −492 36 516 −1,33 14,94 −7 350 545 549
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X −17 850 0 −100,00
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X −1 000 0 −100,00
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X −246 1 000 −19,74
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X −1 100 1 246 −46,89
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X −1 804 2 346 −43,47
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X −4 200 4 150 −50,30
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X −700 8 350 −7,73
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X −100 9 050 −1,09
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X −1 000 9 150 −9,85
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X −1 000 10 150 −8,97
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X −1 000 11 150 −8,23
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −260 37 008 −0,70 13,31 −3 461 492 576
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X −17 098 37 268 −31,45 13,31 −227 574 496 037
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 17 850 54 366 48,88 12,75 227 588 693 166
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 000 36 516 −2,67 13,16 −13 160 480 551
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 1 000 37 516 2,74 12,75 12 750 478 329
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −246 36 516 −0,67 13,13 −3 230 479 455
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 246 36 762 0,67 12,75 3 136 468 716
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 100 36 516 −2,92 13,12 −14 432 479 090
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 1 100 37 616 3,01 12,75 14 025 479 604
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 804 36 516 −4,71 13,11 −23 650 478 725
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 1 804 38 320 4,94 12,75 23 001 488 580
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −4 200 36 516 −10,32 13,10 −55 020 478 360
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 4 200 40 716 11,50 12,75 53 550 519 129
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −700 36 516 −1,88 13,09 −9 163 477 994
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 700 37 216 1,92 12,75 8 925 474 504
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −100 36 516 −0,27 13,08 −1 308 477 629
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 100 36 616 0,27 12,75 1 275 466 854
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 000 36 516 −2,67 13,05 −13 050 476 534
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 1 000 37 516 2,74 12,75 12 750 478 329
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 000 36 516 −2,67 13,00 −13 000 474 708
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 1 000 37 516 2,74 12,75 12 750 478 329
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −1 000 36 516 −2,67 12,99 −12 990 474 343
2005-12-28 2005-12-23 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 1 000 37 516 2,74 12,75 12 750 478 329
2005-07-21 2005-07-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X −2 177 36 516 −5,63 10,00 −21 770 365 160
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)